Featured Research

from universities, journals, and other organizations

Controlling levels of reactive oxygen species breaks cycle of wounds that have refused to heal

Date:
December 17, 2013
Source:
American Society for Cell Biology
Summary:
Researchers have pinpointed the biological activities that are out-of-control in chronically infected wounds that will not heal and then determined potential treatment for these wounds, which can affect patients with type 2 diabetes as well as individuals who are paraplegic or quadriplegic and others with severely limited mobility.

By controlling levels of reactive oxygen species levels within chronic wounds of genetically modified mouse models., Manuela Martins-Green, Ph.D., of the University of California, Riverside (UC Riverside) was able to normalize conditions and heal the wounds, according to research presented on Tuesday, Dec. 17, at the American Society for Cell Biology annual meeting in New Orleans.

Two biological activities are out of control in chronic wound infections, said Dr. Martins-Green. They are: reactive oxygen species (ROS), which are chemically reactive molecules formed by the partial reduction of oxygen, and biofilms that are formed by selective invading bacteria.

ROS, the natural byproduct of normal oxygen metabolism, plays a role in cell signaling and homeostasis. The UC Riverside researchers identified the central role of ROS in maintaining chronic wound infection by inhibiting glutathione peroxidase and catalase, antioxidant enzymes that help maintain normal tissue levels of ROS. Because the antioxidant enzymes were inhibited, the amount of ROS in the wounds soared. The scientists also found that the antioxidant inhibitors were more damaging if administered in combination rather than individually.

Wounds that don't heal are a major danger for patients with type 2 diabetics. A small blister on a patient's foot can evolve into a seriously infected wound that refuses to heal and, if gangrene develops, the patient's foot may have to be amputated.

Such "simple" foot blisters and other diabetic ulcers or sores account for the vast majority of foot and leg amputations in the U.S. today. Individuals who are paraplegic or quadriplegic and anyone with severely limited mobility are also highly vulnerable to these chronic skin wounds as well as pressure ulcers and bedsores. Together, chronic wounds affect an estimated 6.5 million Americans at an annual cost of about $25 billion.

Previous studies in Dr. Martins-Green's lab showed that excessive ROS can induce chronic inflammation, a key characteristic of wounds that do not heal. Biofilms are bacterial defense mechanisms. Together ROS and a biofilm create a sealed toxic environment that can resist all efforts to heal and close a chronic wound.

After inhibiting the ROS inhibitors, Dr. Martins-Green and her colleagues then returned ROS to normal levels by applying two strong antioxidant supplements, vitamin E and N-Acetyl cysteine. Vitamin E reduces the levels of the oxygen radicals, and N-Acetyl cysteine stabilizes the antioxidant enzyme pool, which helps decrease the hydrogen peroxide levels, a contributor to oxidative damage.

As a result of the antioxidant treatment, glutathione peroxidase and catalase activities were restored, and the bacterial biofilm disintegrated in the wound, said Dr. Martins-Green. Restoration of glutathione peroxidase and catalase activities and biofilm disintegration lead to development of healthier wound tissue.

These results show for the first time that, by deliberately modulating specific redox parameters, the researchers were able to create chronic wounds and then reverse chronicity by antioxidant treatment.

"Our findings emphasize the importance of maintaining redox balance during healing and will help in unraveling the mechanisms underlying the development of chronic wounds and hence in identifying potential targets for treatment of these wounds in humans," said Dr. Martins-Green.


Story Source:

The above story is based on materials provided by American Society for Cell Biology. Note: Materials may be edited for content and length.


Cite This Page:

American Society for Cell Biology. "Controlling levels of reactive oxygen species breaks cycle of wounds that have refused to heal." ScienceDaily. ScienceDaily, 17 December 2013. <www.sciencedaily.com/releases/2013/12/131217123900.htm>.
American Society for Cell Biology. (2013, December 17). Controlling levels of reactive oxygen species breaks cycle of wounds that have refused to heal. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/12/131217123900.htm
American Society for Cell Biology. "Controlling levels of reactive oxygen species breaks cycle of wounds that have refused to heal." ScienceDaily. www.sciencedaily.com/releases/2013/12/131217123900.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins